A Phase 3 Randomized, Placebo-Controlled, Double-Blind Prgram to Evaluate Efficacy and Safety of Upadacitinib in Adult Subjects with Axial Spondyloarthritis

  • Antony, Anna (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description

NMA HREC Reference Number: 58566
NMA SSA Reference Number: SSA/58566/MonH-2020-229726(v1)
Monash Health Reference: RES-19-0000-888A
Effective start/end date16/09/208/09/25


  • clinical trial
  • treatment safety
  • treatment
  • phase 3 study
  • arthritis